Febuxostat increases all-cause and CV mortality compared with allopurinol
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Febuxostat Increases All-cause and CV Mortality Compared With Allopurinol." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314530/all/Febuxostat_increases_all_cause_and_CV_mortality_compared_with_allopurinol.
Febuxostat increases all-cause and CV mortality compared with allopurinol. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314530/all/Febuxostat_increases_all_cause_and_CV_mortality_compared_with_allopurinol. Accessed September 16, 2024.
Febuxostat increases all-cause and CV mortality compared with allopurinol. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314530/all/Febuxostat_increases_all_cause_and_CV_mortality_compared_with_allopurinol
Febuxostat Increases All-cause and CV Mortality Compared With Allopurinol [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 September 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314530/all/Febuxostat_increases_all_cause_and_CV_mortality_compared_with_allopurinol.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Febuxostat increases all-cause and CV mortality compared with allopurinol
ID - 1314530
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314530/all/Febuxostat_increases_all_cause_and_CV_mortality_compared_with_allopurinol
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -